Thomas Steyer’s NuCana NCNA Stock Holding History

Thomas Steyer’s Portfolio NCNA Stock Details NCNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-80	Closed	-$4.04M	–	99
2017 Q4	$4.04M	Hold	80	–	–	0.03%	74
2017 Q3	$7.35M	Buy	+80	New	+$6.9M	0.07%	74

Other funds holding NCNA

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Thomas Steyer's NCNA Position: Q1 2018 in Review

Thomas Steyer sold out of NuCana (NCNA) in Q1 2018, closing a stake of 80 shares — an estimated $4.04M sold.

Thomas Steyer first reported a position in NCNA in Q3 2017 and held it in 2 quarters. The position peaked at $7.35M in Q3 2017. 16 funds tracked by Wall St. Rank hold NCNA as of Q1 2018.

Thomas Steyer reported no remaining NuCana position as of Q1 2018 after selling out during the quarter.
Thomas Steyer sold 80 NuCana shares in Q1 2018, an estimated $4.04M.
Thomas Steyer first reported a position in NuCana in Q3 2017 and held it in 2 quarters.
Thomas Steyer's NuCana position peaked at $7.35M in Q3 2017.
16 funds tracked by Wall St. Rank held NuCana as of Q1 2018.

Based on Farallon Capital Management's 13F filing for Q1 2018, filed 15 May 2018.